Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Circ Cardiovasc Genet. 2014 Dec 31;8(2):389–397. doi: 10.1161/CIRCGENETICS.114.000597

Table 2.

Genome-wide significant loci for circulating concentrations of hepatocyte growth factor (HGF), soluble Tie-2 (sTie-2) and Angiopoietin-2 (Ang-2); The most significant single nucleotide polymorphisms for each locus and biomarker are shown.

Discovery sample,
FHS Third Generation cohort
Replication sample, SHIP-1

Biomarker rsID Chr N Coded/
Non-Coded
Allele
MAF Beta (SE) p-value Closest
Gene
N MAF Beta (SE) p-value
HGF
rs5745687 7 3571 T/C 0.077 −0.099
(0.011)
3.64×10−19 HGF
Ang-2
rs8176746 9 3574 T/G 0.077 0.111
(0.020)
2.07×10−8 ABO 3188 0.096 0.061
(0.019)
0.001
rs2442517 8 3574 G/A 0.474 0.059
(0.011)
5.05×10−8 MCPH1 3188 0.461 0.043
(0.011)
8.39×10−5

sTie-2
rs2273720 9 3574 C/A 0.056 0.265 (0.016) 2.40×10−65 Tie-2 3184 0.056 0.237 (0.018) 2.70×10−38
rs8176693 9 3574 T/C 0.077 0.155 (0.013) 1.84×10−33 ABO 3184 0.096 0.157 (0.014) 2.53×10−30

Chr. indicates chromosome; FHS, Framingham Heart Study; HGF, hepatocyte growth factor; Ang-2, Angiopoietin-2; MAF, minor allele frequency; SE, standard error; SHIP, Study of Health in Pomerania; SNP, single nucleotide polymorphism.